Squarepoint
GDRX icon

Squarepoint’s GoodRx Holdings GDRX Stock Holding History

Squarepoint’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,100
Closed -$47K – 4869
2024
Q4 		$47K Buy
+10,100
New +$55.5K ﹤0.01% 4854
2022
Q1 		– Sell
-90,200
Closed -$2.95M – 3093
2021
Q4 		$2.95M Sell
90,200
-24,100
-21% -$970K 0.01% 1042
2021
Q3 		$4.69M Buy
114,300
+19,800
+21% +$718K 0.01% 805
2021
Q2 		$3.4M Buy
94,500
+57,300
+154% +$2.11M 0.01% 908
2021
Q1 		$1.45M Buy
+37,200
New +$1.67M 0.01% 1264

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Squarepoint's GDRX Position: Q2 2026 in Review

Squarepoint reduced its GoodRx Holdings (GDRX) stake by 9.6% in Q2 2026, selling an estimated $20.2K and leaving 74,770 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #4023.

Squarepoint first reported a position in GDRX in Q3 2020 and has held it in 17 quarters since. The position peaked at $11.2M in Q3 2020. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Squarepoint held 74,770 shares of GoodRx Holdings worth $215K as of Q2 2026.
  • Squarepoint sold 7,946 GoodRx Holdings shares in Q2 2026, an estimated $20.2K.
  • GoodRx Holdings made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4023 holding.
  • Squarepoint first reported a position in GoodRx Holdings in Q3 2020 and has held it in 17 quarters since.
  • Squarepoint's GoodRx Holdings position peaked at $11.2M in Q3 2020.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.